Listed by the USPTO as PUTTLITZ, KARL J
Tech Center 1600 • Art Units: 1621 1624 1642 1643 1644 1646 1671
This examiner grants 69% of resolved cases
Karl J. Puttlitz is an examiner in Tech Center 1600 and Art Unit 1621. He has 1434 resolved cases. His allowance rate is 69.2 percent. The interview lift is 18.5 percent, suggesting that interviews are a part of the prosecution process compared to the 69.2 percent baseline. This 18.5 percent lift indicates that verbal engagement is a way to address examiner concerns.
The median days to allowance is 932. His top companies include The Board of Trustees of the Leland Stanford Junior University, Genequantum Healthcare (Suzhou) Co. Ltd., and Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. Firms like BakerHostetler, HOXIE & ASSOCIATES LLC, and BROWN RUDNICK LLP are the top representatives. The 69.2 percent allowance rate and 932 median days to allowance indicate a prosecution path. With 1434 resolved cases, these metrics are established and provide a guide for practitioners appearing in Art Unit 1621. The 18.5 percent interview lift is a factor for consideration.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18695618 | PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT | Non-Final OA | SONY GROUP CORPORATION |
| 18461170 | CLIPTAC COMPOSITION | Non-Final OA | OTSUKA PHARMACEUTICAL CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy69.2% of resolved applications examined by Karl J Puttlitz were allowed (1,434 resolved cases), compared with 46.0% across Art Unit 1621 over the last five years.
This examiner's interview lift is +18.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Karl J Puttlitz took 932 days on average from filing to allowance.
Karl J Puttlitz examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
